Cargando…

Potential resistance to SARS-CoV-2 infection in lysosomal storage disorders

Detalles Bibliográficos
Autores principales:	Pieroni, Maurizio, Pieruzzi, Federico, Mignani, Renzo, Graziani, Francesca, Olivotto, Iacopo, Riccio, Eleonora, Ciabatti, Michele, Limongelli, Giuseppe, Manna, Raffaele, Bolognese, Leonardo, Pisani, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7929028/ https://www.ncbi.nlm.nih.gov/pubmed/34221376 http://dx.doi.org/10.1093/ckj/sfab045

Ejemplares similares

The GALA project: practical recommendations for the use of migalastat in clinical practice on the basis of a structured survey among Italian experts
por: Chimenti, Cristina, et al.
Publicado: (2020)

Safety of a protocol for reduction of agalsidase beta infusion time in Fabry disease: An Italian multi-centre study
por: Mignani, Renzo, et al.
Publicado: (2021)

FAbry STabilization indEX (FASTEX): an innovative tool for the assessment of clinical stabilization in Fabry disease
por: Mignani, Renzo, et al.
Publicado: (2016)

New insights from the application of the FAbry STabilization indEX in a large population of Fabry cases
por: Mignani, Renzo, et al.
Publicado: (2018)

New insights from the application of the FAbry STabilization indEX in a large population of Fabry cases
por: Mignani, Renzo, et al.
Publicado: (2019)

Cytosorb treatment in severe COVID-19 cardiac and pulmonary disease
por: Ciabatti, Michele, et al.
Publicado: (2021)

Impact of COVID-19 pandemic on patients with Fabry disease: An Italian experience
por: Riccio, Eleonora, et al.
Publicado: (2020)

COVID-19 mRNA vaccination in patients with previous myocarditis
por: Pieroni, Maurizio, et al.
Publicado: (2022)

Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases
por: Faverio, Paola, et al.
Publicado: (2019)

Aortopathies in mouse models of Pompe, Fabry and Mucopolysaccharidosis IIIB lysosomal storage diseases
por: Belfiore, Maria Paola, et al.
Publicado: (2020)

Cardiogenic Shock in Obstructive Hypertrophic Cardiomyopathy Plus Apical Ballooning: Management With VA-ECMO and Myectomy
por: Caniato, Flavia, et al.
Publicado: (2021)

Lysosomes and Lysosomal Storage Diseases
por: Noebels, Jeffrey L.
Publicado: (1981)

Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease?
por: Duro, Giovanni, et al.
Publicado: (2018)

Lysosomal storage disorders
por: Cabrera-Salazar, Mario A, et al.
Publicado: (2007)

Lysosomal storage diseases
por: Ferreira, Carlos R., et al.
Publicado: (2017)

Lysosomal storage disorders: The cellular impact of lysosomal dysfunction
por: Platt, Frances M., et al.
Publicado: (2012)

Lysosomal positioning diseases: beyond substrate storage
por: Scerra, Gianluca, et al.
Publicado: (2022)

Autophagy in lysosomal storage disorders
por: Lieberman, Andrew P., et al.
Publicado: (2012)

Biomarkers in Lysosomal Storage Diseases
por: Bobillo Lobato, Joaquin, et al.
Publicado: (2016)

Lysosomal Storage Disorders and Malignancy
por: Pastores, Gregory M., et al.
Publicado: (2017)

Neonatal Expanded Screening toward lysosomal storage disorders
por: Burlina, Alberto, et al.
Publicado: (2015)

Lysosomal Storage Disorders Shed Light on Lysosomal Dysfunction in Parkinson’s Disease
por: Blumenreich, Shani, et al.
Publicado: (2020)

Lysosomal Storage Diseases—Regulating Neurodegeneration
por: Onyenwoke, Rob U., et al.
Publicado: (2016)

Neuroinflammatory paradigms in lysosomal storage diseases
por: Bosch, Megan E., et al.
Publicado: (2015)

Mitochondrial Dysfunction in Lysosomal Storage Disorders
por: de la Mata, Mario, et al.
Publicado: (2016)

Modeling Lysosomal Storage Diseases in the Zebrafish
por: Zhang, T., et al.
Publicado: (2020)

Therapeutic Approaches in Lysosomal Storage Diseases
por: Fernández-Pereira, Carlos, et al.
Publicado: (2021)

The Role of Exosomes in Lysosomal Storage Disorders
por: Gleason, Adenrele M., et al.
Publicado: (2021)

Evidence of evolution towards left midventricular obstruction in severe Anderson–Fabry cardiomyopathy
por: Graziani, Francesca, et al.
Publicado: (2020)

Mechanisms of Mitochondrial Dysfunction in Lysosomal Storage Disorders: A Review
por: Stepien, Karolina M., et al.
Publicado: (2020)

Role of serial cardiac (18)F-FDG PET-MRI in Anderson–Fabry disease: a pilot study
por: Nappi, Carmela, et al.
Publicado: (2021)

Potential Treatment of Lysosomal Storage Disease through Modulation of the Mitochondrial—Lysosomal Axis
por: Kuk, Myeong Uk, et al.
Publicado: (2021)

Molecular Mechanisms in Lysosomal Storage Diseases: From Pathogenesis to Therapeutic Strategies
por: De Pasquale, Valeria, et al.
Publicado: (2022)

Prognostic significance of right ventricular hypertrophy and systolic function in Anderson–Fabry disease
por: Graziani, Francesca, et al.
Publicado: (2020)

Targeted Polymeric Nanoparticles for Brain Delivery of High Molecular Weight Molecules in Lysosomal Storage Disorders
por: Salvalaio, Marika, et al.
Publicado: (2016)

A strange epigastric pain
por: Riccio, Eleonora, et al.
Publicado: (2014)

Molecular study of lysosomal storage disorders in India
por: Sheth, Jayesh
Publicado: (2014)

Molecular basis of lysosomal storage disorders in India
por: Kondurkar, Shweta P, et al.
Publicado: (2014)

Highlights on Genomics Applications for Lysosomal Storage Diseases
por: La Cognata, Valentina, et al.
Publicado: (2020)

Synaptic Function and Dysfunction in Lysosomal Storage Diseases
por: Rebiai, Rima, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2hukbspknm4egcqkpp5llqgi4i